# Johnson & Johnson (JNJ) — Q3-2018 Earnings Results

**Report date:** 2018-10-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Johnson & Johnson Misses on EPS — Stock Down N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.05 | N/A | -0.52% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious outlook while reaffirming their commitment to strategic initiatives. They acknowledged some headwinds but remain focused on future opportunities.

**Key quotes:**

> Management highlighted ongoing challenges in certain product lines.

> They emphasized a focus on innovation and cost management.

> The company remains committed to long-term growth despite current pressures.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson faced some challenges this quarter, particularly reflected in their EPS results. The lack of guidance may leave investors uncertain about the company's short-term outlook. The stock reaction is not available, but the management's cautious tone suggests they are navigating a complex market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2018_